NCT07634640RecruitingEarly phase 1
Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction
Omega-3 Fatty Acids and Myocardial Inflammation in HFpEF: Preliminary Data and Next Steps
Source: ClinicalTrials.gov · Last updated 9 Jun 2026
Brief summary (registry, in English)
Subjects undergo a gadolinium-based CMR followed by an iron infusion and then a repeat CMR in 72 hours
- Status (registry)
- Recruiting
- Phase (registry)
- Early phase 1
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- First submitted
- 4 Jun 2026
- Start date
- 3 Nov 2023
- Primary completion date
- 31 May 2027
- Lead sponsor
- University of Florida
- Diseases
- Heart failure
- NCT number
- NCT07634640
What you commit to
- Study type: Interventional · Early phase 1
- Planned participants: 70
- From 3 Nov 2023 to the primary completion date, 31 May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Renal insufficiency
Who the study is looking for
- HFpEF
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Florida Coordinator of this site? Confirm its status | Gainesville | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.